Immune cell landscape and immunotherapy of medulloblastoma
ABSTRACT Medulloblastoma is the most common primary pediatric malignancy of the central nervous system. Recurrent and refractory patients account for approximately 30% of them. Immune cells are an important component of the brain tumor microenvironment, including tumor‐associated macrophages, T lymp...
| Published in: | Pediatric Investigation |
|---|---|
| Main Authors: | Jin Zhang, Tianyou Wang |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-12-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ped4.12261 |
Similar Items
Medulloblastoma: Immune microenvironment and targeted nano-therapy
by: Qiyue Wang, et al.
Published: (2022-03-01)
by: Qiyue Wang, et al.
Published: (2022-03-01)
Medulloblastoma: biology and immunotherapy
by: Alessandro Poggi, et al.
Published: (2025-07-01)
by: Alessandro Poggi, et al.
Published: (2025-07-01)
Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma
by: Jin Zhang, et al.
Published: (2022-07-01)
by: Jin Zhang, et al.
Published: (2022-07-01)
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy
by: Gauthier M, et al.
Published: (2024-06-01)
by: Gauthier M, et al.
Published: (2024-06-01)
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution
by: Jack Hedberg, et al.
Published: (2023-09-01)
by: Jack Hedberg, et al.
Published: (2023-09-01)
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
by: Lola Boutin, et al.
Published: (2025-12-01)
by: Lola Boutin, et al.
Published: (2025-12-01)
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets
by: Rui Ferreira Marques, et al.
Published: (2023-02-01)
by: Rui Ferreira Marques, et al.
Published: (2023-02-01)
The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies
by: Mengyuan Hu, et al.
Published: (2024-07-01)
by: Mengyuan Hu, et al.
Published: (2024-07-01)
Decoding the Roles of Astrocytes and Hedgehog Signaling in Medulloblastoma
by: Terence Teixeira Duarte, et al.
Published: (2021-08-01)
by: Terence Teixeira Duarte, et al.
Published: (2021-08-01)
Multifocal medulloblastoma in an adult: a case report and review of the literature
by: Cha Luo, et al.
Published: (2025-05-01)
by: Cha Luo, et al.
Published: (2025-05-01)
Chemotherapy For Medulloblastoma
by: J Gordon Millichap
Published: (1988-11-01)
by: J Gordon Millichap
Published: (1988-11-01)
Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution – A role for immunotherapy
by: Francis Yew Fu Tieng, et al.
Published: (2022-08-01)
by: Francis Yew Fu Tieng, et al.
Published: (2022-08-01)
WNT: an unexpected tumor suppressor in medulloblastoma
by: Branavan Manoranjan, et al.
Published: (2020-11-01)
by: Branavan Manoranjan, et al.
Published: (2020-11-01)
Decoding the immune landscape in Ewing sarcoma pathogenesis: The role of tumor infiltrating immune cells and immune milieu
by: Rajiv Ranjan Kumar, et al.
Published: (2025-06-01)
by: Rajiv Ranjan Kumar, et al.
Published: (2025-06-01)
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
by: Changlin Yang, et al.
Published: (2024-08-01)
by: Changlin Yang, et al.
Published: (2024-08-01)
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination
by: Vahan Martirosian, et al.
Published: (2021-06-01)
by: Vahan Martirosian, et al.
Published: (2021-06-01)
A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy
by: Rui Li, et al.
Published: (2025-05-01)
by: Rui Li, et al.
Published: (2025-05-01)
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy
by: Ningning He, et al.
Published: (2024-02-01)
by: Ningning He, et al.
Published: (2024-02-01)
Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
by: Yuli Jian, et al.
Published: (2021-03-01)
by: Yuli Jian, et al.
Published: (2021-03-01)
Recapitulating the immune microenvironment in pediatric brain cancer: preclinical modeling strategies
by: Adip G. Bhargav, et al.
Published: (2025-10-01)
by: Adip G. Bhargav, et al.
Published: (2025-10-01)
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)
by: Jiali Yao, et al.
Published: (2025-01-01)
Characterization of the immune cell infiltration patterns in lung adenocarcinoma to facilitate immunotherapy
by: Haili Li, et al.
Published: (2025-02-01)
by: Haili Li, et al.
Published: (2025-02-01)
Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma
by: Qizhi Fan, et al.
Published: (2024-04-01)
by: Qizhi Fan, et al.
Published: (2024-04-01)
Establishment and identification of a medulloblastoma transplantable tumor strain PUMC-MBT1
by: WANG Shi-zun, ZHANG Dan, GE Ming, FENG Hai-liang, LIU Yu-qin
Published: (2022-09-01)
by: WANG Shi-zun, ZHANG Dan, GE Ming, FENG Hai-liang, LIU Yu-qin
Published: (2022-09-01)
Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints
by: Hanhui Jing, et al.
Published: (2025-06-01)
by: Hanhui Jing, et al.
Published: (2025-06-01)
Extraneural metastases in medulloblastoma
by: V M F Muoio, et al.
Published: (2011-01-01)
by: V M F Muoio, et al.
Published: (2011-01-01)
Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation
by: Alejandro Castillo-Peña, et al.
Published: (2023-10-01)
by: Alejandro Castillo-Peña, et al.
Published: (2023-10-01)
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
by: Sumana Shrestha, et al.
Published: (2021-06-01)
by: Sumana Shrestha, et al.
Published: (2021-06-01)
Targeting GABA signaling in the tumor microenvironment: implications for immune cell regulation and immunotherapy resistance
by: Yuanqing Zhao, et al.
Published: (2025-08-01)
by: Yuanqing Zhao, et al.
Published: (2025-08-01)
Paediatric desmoplastic medulloblastoma – Surgical treatment, adjuvant therapy, outcome survival (case series study)
by: Raad Ahmed Hussein, et al.
Published: (2020-03-01)
by: Raad Ahmed Hussein, et al.
Published: (2020-03-01)
Proteomic analysis of Medulloblastoma reveals functional biology with translational potential
by: Samuel Rivero-Hinojosa, et al.
Published: (2018-06-01)
by: Samuel Rivero-Hinojosa, et al.
Published: (2018-06-01)
Medulloblastoma Presenting as Severe Headache during Pregnancy: A Case Report and Review of the Literature
by: Francesca Gabriela Paslaru, et al.
Published: (2022-01-01)
by: Francesca Gabriela Paslaru, et al.
Published: (2022-01-01)
Prognosis of Medulloblastoma
by: J Gordon Millichap
Published: (1998-08-01)
by: J Gordon Millichap
Published: (1998-08-01)
Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma
by: Eric M. Thompson, et al.
Published: (2024-02-01)
by: Eric M. Thompson, et al.
Published: (2024-02-01)
Dynamic profiling of medulloblastoma surfaceome
by: David Bakhshinyan, et al.
Published: (2023-07-01)
by: David Bakhshinyan, et al.
Published: (2023-07-01)
Immune landscape and immunotherapy for penile cancer
by: Yaxiong Tang, et al.
Published: (2022-11-01)
by: Yaxiong Tang, et al.
Published: (2022-11-01)
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
by: Shonik Ganjoo, et al.
Published: (2023-04-01)
by: Shonik Ganjoo, et al.
Published: (2023-04-01)
Editorial: Understanding the interplay between tumor immune microenvironment and neoantigens for improved immunotherapy
by: Sheefa Mirza, et al.
Published: (2025-10-01)
by: Sheefa Mirza, et al.
Published: (2025-10-01)
Tumor-associated macrophages correlate with better outcome in SHH medulloblastoma
by: Jin Zhang, et al.
Published: (2025-04-01)
by: Jin Zhang, et al.
Published: (2025-04-01)
Tumor secretome shapes the immune landscape during cancer progression
by: Jianqiang Yang, et al.
Published: (2025-02-01)
by: Jianqiang Yang, et al.
Published: (2025-02-01)
Similar Items
-
Medulloblastoma: Immune microenvironment and targeted nano-therapy
by: Qiyue Wang, et al.
Published: (2022-03-01) -
Medulloblastoma: biology and immunotherapy
by: Alessandro Poggi, et al.
Published: (2025-07-01) -
Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma
by: Jin Zhang, et al.
Published: (2022-07-01) -
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy
by: Gauthier M, et al.
Published: (2024-06-01) -
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution
by: Jack Hedberg, et al.
Published: (2023-09-01)
